Pharmaceutical Industry discussion, review, analysis, news and information.

Scientists from Barcelona and Birmingham have discovered a new way that drugs can attach themselves to DNA which led to the discovery of a synthetic drug agent that targets and binds to the centre of a 3-way junction in the DNA.

This finding provides a crucial step forward for those who are developing drugs to combat cancer and other diseases which will hopefully lead to a new approach in designing drugs.

“This is a significant step in drug design for DNA recognition and it is an absolutely crucial step forward for medical science researchers worldwide who are working on new drug targets for cancer and other diseases,” said Mike Hannon, from the University of Birmingham's School of Chemistry.

 "This discovery will revolutionise the way that we think about how to design molecules to interact with DNA. It will send chemical drug research off on a new tangent. By targeting specific structures in the DNA scientists may finally start to achieve control over the way our genetic information is processed and apply that to fight disease."

Read more at the Drug Researcher.